MedPath

Treatment of Early Nasal Polyposis With Topical Triamcinolone

Phase 1
Terminated
Conditions
Nasal Polyps
Interventions
Drug: Saline soaked sponge
Registration Number
NCT01222871
Lead Sponsor
Steward St. Elizabeth's Medical Center of Boston, Inc.
Brief Summary

The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.

Detailed Description

nasopore, a bio-absorbable nasal dressing, may offer an alternative route of sustained steroid drug delivery. The use of topical targeted intranasal steroids may prevent the routine adverse effects of oral steroids while maintaining the same therapeutic / clinical efficacy.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Age > 18 years
  • Patients with early nasal polyposis
Exclusion Criteria
  • Age < 18 years
  • Patients with active sinus infections
  • Patients on long term steroids
  • Allergy or sensitivity to steroids
  • Patients with Antrochoanal polyps
  • Patients who received topical steroids by bio-resorbable sponge or oral steroids

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Control GroupSaline soaked spongeSaline soaked sponge
TriamcinoloneTriamcinoloneTriamcinolone soaked nasopore dressing
Primary Outcome Measures
NameTimeMethod
Nasal Endoscopic Exam Findings .2 weeks, 6 weeks, 12 weeks were not collected from any participant.

nasal endoscopic exam findings at 2 weeks, 6 weeks and 12 weeks were not collected from any participant.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St. Elizabeth's Medical Center, 736 Cambridge St

🇺🇸

Brighton, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath